---
title: "SANAI HEALTH GP: Sale of subsidiary equity"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/265172352.md"
description: "SANAI HEALTH GP announced that on November 10, 2025, the company entered into an agreement with the buyer to sell equity in its subsidiary for approximately RMB 18.69 million, which will be settled in cash. The sale constitutes a transaction that must be disclosed by the company but is exempt from the requirement for shareholder approval. The highest applicable percentage for the sale exceeds 5% but is less than 25%. After the completion of the transaction, the company will no longer hold any equity in the target company, and the target company will no longer be a subsidiary of the company"
datetime: "2025-11-10T14:02:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/265172352.md)
  - [en](https://longbridge.com/en/news/265172352.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/265172352.md)
---

# SANAI HEALTH GP: Sale of subsidiary equity

SANAI HEALTH GP announced that on November 10, 2025, the company entered into an agreement with the buyer to sell the equity of its subsidiary for approximately RMB 18.69 million, which will be settled in cash. The sale constitutes a transaction that the company must disclose, but is exempt from the requirement for shareholder approval. The highest applicable percentage for the sale exceeds 5% but is less than 25%. After the completion of the transaction, the company will no longer hold any equity in the target company, and the target company will no longer be a subsidiary of the company

### Related Stocks

- [01889.HK](https://longbridge.com/en/quote/01889.HK.md)

## Related News & Research

- [Fusen Pharmaceutical Wins China Nod for Peramivir Flu Injection](https://longbridge.com/en/news/290914836.md)
- [MMG Wins Vienna Listing for US$800 Million Convertible Bonds](https://longbridge.com/en/news/290591233.md)
- [Spectral Medical says FDA files PMA application for PMX therapy](https://longbridge.com/en/news/290819659.md)
- [Samsung invests $110M in healthcare firm GRAIL to expand cancer test into Korea, Asia](https://longbridge.com/en/news/290946261.md)
- [QingSong Health Chair Extends Lock-Up on Controlling Stake to 2027](https://longbridge.com/en/news/290465871.md)